Parenteral Drugs India has informed that a meeting of the Board of Directors of the Company will be held on December 30, 2015, to consider disinvestment of shares held by the Company in its non-operational Subsidiary Companies, declaration of defunct of non-working Subsidiary companies and other items as per agenda of the meeting. As per the provisions of regulation 9 and Schedule B of the SEBI (Prohibition of Insider Trading) Regulations, 2015, in respect of Company’s Code of Conduct to regulate, monitor and report trading by insiders for Prevention of Insider Trading in the Equity shares and for the aforesaid purpose the ‘Trading Window’ of the Company shall remain closed from the date of intimation i.e. December 26, 2015 to January 01, 2016 and will open on January 02, 2016 for insiders accordingly.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1808.50 |
Dr. Reddys Lab | 1342.45 |
Cipla | 1472.45 |
Lupin | 2147.55 |
Zydus Lifesciences | 973.90 |
View more.. |